Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis.
about
Ovarian serous carcinoma: recent concepts on its origin and carcinogenesisRecent concepts of ovarian carcinogenesis: type I and type IIIdentification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implantsFlutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence.Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options.Coming into focus: the nonovarian origins of ovarian cancer.Tubal origin of ovarian low-grade serous carcinoma.Fallopian metaplastic papillary tumour: an atypical transdifferentiation of the tubal epithelium?Ovarian Cancer Is an Imported Disease: Fact or Fiction?Characterization of the immune cell repertoire in the normal fallopian tube.Microscopic lesions of fallopian tubes in endometrioid carcinoma of the endometrium: How effective are the macroscopic tubal sampling techniques?Ovarian cancer stroma: pathophysiology and the roles in cancer development.Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC)Gonadoblastoma and Papillary Tubal Hyperplasia in Ovotesticular Disorder of Sexual Development.Biomarkers and endosalpingiosis in the ovarian and tubal microenvironment of women at high-risk for pelvic serous carcinoma.Primary fallopian tube carcinoma arising in the setting of chronic pelvic inflammatory disease.The role of the fallopian tube in the origin of ovarian cancer.Early preinvasive lesions in ovarian cancer.Subtypes of Ovarian Cancer and Ovarian Cancer Screening.Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features.Key features of extrauterine pelvic serous tumours (fallopian tube, ovary, and peritoneum).Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.Endosalpingiosis in peritoneal washings in women with benign gynecologic conditions: thirty-eight cases confirmed with paired box-8 immunohistochemical staining and correlation with surgical biopsy findings.The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded.Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.Comparison of the Classical Method and SEE-FIM Protocol in Detecting Microscopic Lesions in Fallopian Tubes with Gynecological Lesions.A guided tour of selected issues pertaining to metastatic carcinomas involving or originating from the gynecologic tract.Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors.
P2860
Q26822545-64287D9C-E511-4ED2-A889-E0DE62549C38Q27009487-908182FC-96FB-4BD0-8AAC-E589463B7F45Q30252854-EC562484-2567-4E7F-AC04-3325FE0F82B1Q33862255-3E67B481-07BF-4808-9D13-3FDDA37F17A3Q34135327-7DC54668-F666-474C-9CCC-243F59BE90D0Q34317865-15E65C8E-01E6-410A-9076-7ACBD9F53CEDQ34378112-DB263F49-75A0-4D5D-8B6F-EB2F92A848F4Q34383567-4EC77133-3CED-4BF5-9ECD-6221E72EFC58Q35198968-6B19ED7D-C857-4469-88A2-E27EC59BEE9CQ35878320-57F6112F-6743-4570-90E0-DDD3F874C274Q36198864-E934E3C5-1A1B-4F58-8C3F-CFB15D9C9715Q36817471-73FD3199-F0E3-4B6A-BB06-F6A438BD99D3Q37017056-1667D811-71F0-4626-AAEC-B0A096224AC3Q37163464-CBA0C2AD-D447-4BB0-9350-15DF8669208BQ37395155-2690C985-56ED-4DA8-AFA9-B4FE90175076Q37516304-C31BC100-92F4-49AA-A578-63E96734E0FAQ37553928-BBDE6158-AF67-4DF6-8C09-C5A46A4048E5Q37608093-BBB4A942-E0EA-46BD-8071-953284A5E99CQ37719090-EAB40312-42D8-4533-BB4C-EF6683EDAE0DQ37729974-3EE7D32A-F989-4B0C-8539-6780A4E2865BQ37982940-0D1C92AD-48F0-4EBC-B28E-F674CDCD90BEQ37988903-5FD30F44-B4AD-4E84-BC82-A2F7E7E696AAQ38067435-62B97B7B-2212-4140-8B11-EC816E3608E6Q38106920-9B2565C3-D59F-4652-AE1C-471486C8AD14Q38787667-F3D1892F-1DEA-4C6F-8BD0-86DFFA6FB3D2Q41006936-728CB613-7CC6-48A2-86EC-C11545274B71Q49184692-CE445587-9B37-4FD8-A1F2-FB0F6A46BEF5Q49724000-F2C74C62-FE3B-470A-A792-415811C391DAQ51876753-1E2B0AAD-7FA5-4EC6-9181-97CA575CAC50
P2860
Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Papillary tubal hyperplasia: ...... mplants, and endosalpingiosis.
@ast
Papillary tubal hyperplasia: ...... mplants, and endosalpingiosis.
@en
type
label
Papillary tubal hyperplasia: ...... mplants, and endosalpingiosis.
@ast
Papillary tubal hyperplasia: ...... mplants, and endosalpingiosis.
@en
prefLabel
Papillary tubal hyperplasia: ...... mplants, and endosalpingiosis.
@ast
Papillary tubal hyperplasia: ...... mplants, and endosalpingiosis.
@en
P2093
P2860
P1476
Papillary tubal hyperplasia: ...... implants, and endosalpingiosis
@en
P2093
Charlotte Gerd Hannibal
Ie-Ming Shih
Jette Junge
Robert J Kurman
Russell Vang
P2860
P304
P356
10.1097/PAS.0B013E318229449F
P407
P577
2011-11-01T00:00:00Z